Physician profile
Jerold Goldstein
NPI 1740251750
$2,323.80
in general payments reported to CMS, 2019-2025
17 companies · $75.62 in 2025
The $75.62 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $423 · 2020: $249 · 2021: $309 · 2022: $415 · 2023: $714 · 2024: $139 · 2025: $75.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $929.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $928.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $608.45 | 2021-2024 | Puraply |
| Horizon Therapeutics Plc | $358.95 | 2020-2023 | Krystexxa |
| Boston Scientific Corporation | $257.23 | 2019-2023 | |
| Paratek Pharmaceuticals, INC. | $228.71 | 2020-2025 | Nuzyra |
| Stryker Corporation | $147.65 | 2019 | |
| Treace Medical Concepts, INC. | $125.00 | 2023 | |
| Merck Sharp & Dohme LLC | $118.87 | 2019 | |
| Djo, LLC | $77.23 | 2023-2025 | Cmf |
| Abbvie INC. | $71.77 | 2022 | |
| Medtronic Vascular, INC. | $66.90 | 2020 | |
| Next Science LLC | $52.90 | 2023 | Xperience, Blastx, Surgx |
| Smith+Nephew, INC. | $47.77 | 2019-2023 | Grafix, Regranex, Collagenase Santyl |
| Kerecis Limited | $47.12 | 2019-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Medtronic, INC. | $43.92 | 2021-2024 | Venaseal |
| Globus Medical, INC. | $34.01 | 2025 | Senza |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reprise Biomedical, INC. | $24.33 | 2023 | Miro3d |
| Fidia Pharma USA INC. | $12.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerold Goldstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.